Effects vary and depend heavily on proper dosing and supervision
And thats because we're waiting on more long-term data that shows there is a sustained clinical benefit with these medications. To note: Wellmark covers GLP-1s when used as a treatment for type 2 diabetes
[66] Ibid [67] Christensen J, Grnborg TK, Srensen MJ, et al
FOR IMMEDIATE RELEASE FROM MARY ANN LIEBERT, INC., PUBLISHERS New Rochelle, NY, January 8, 2025 A new study found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer
It is listed as a rare adverse reaction in UK product information for both oral and injectable B12 preparations, and most people tolerate B12 supplements well even at high doses